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Abstract: Glioblastoma multiforme (GBM) is the most common and most aggressive malignant 
primary brain tumor in humans. Current GBM treatment includes surgery, radiation therapy, and 
chemotherapy, sometimes supplemented with novel therapies. Despite recent advances, survival 
of GBM patients remains poor. Major challenges in GBM treatment are drug delivery across the 
blood–brain barrier, restriction of damage to healthy brain tissues, and limitation of resistance 
to therapies. This article reviews recent advances in the application of magnetic nanoparticles 
(MNPs), gold nanorods (GNRs), and carbon nanotubes (CNTs) for hyperthermia ablation of 
GBM. First, the article introduces GBM, its current treatment, and hyperthermia as a potential 
modality for the management of GBM. Second, it introduces MNPs, GNRs, and CNTs as inor-
ganic agents to induce hyperthermia in GBM. Third, it discusses different methodologies for 
synthesis of each inorganic agent. Finally, it reviews in vitro and in vivo studies in which MNPs, 
GNRs, and CNTs have been applied for hyperthermia ablation and drug delivery in GBM.
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Introduction
Glioblastoma multiforme
Gliomas are heterogeneous central nervous system tumors.1 Glioblastoma multiforme 
(GBM) is the most frequent and malignant type of glioma, and despite advances in 
diagnosis and treatment of GBM, median survival of GBM patients remains less 
than 15 months.2 There are at least two factors that make GBM treatment extremely 
difficult. First, the brain has limited capacity to repair itself. Second, GBM is highly 
invasive and resistant to therapies.3
Conventional GBM therapies consist of surgery, radiotherapy (RT), and 
  chemotherapy. Objectives of surgery range from merely confirmation of the diagnosis 
or alleviation of symptoms due to mass effects to aggressive attempts to improve quality 
of life and prolong survival of the patient.3 RT is one of the oldest and most common 
treatment options for GBM patients. It is based on generation of electrons and free 
radicals by ionizing radiation to damage  deoxyribonucleic acid (DNA). Early clinical 
trials revealed a modest, yet undeniable efficacy of RT in treating GBM. However, there 
are several limitations of RT including risk of necrosis, permanent neuronal damage, 
and radio resistance of certain tumor types (Figure 1).4
Temozolomide has been the mainline chemotherapy drug for GBM treatment for 
over 10 years.5 Temozolomide, an oral alkylating agent, is a second-generation imi-
dazotetrazine derivative, which exhibits cytotoxic effects by methylation of specific 
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Bevacizumab is often used as adjuvant therapy for GBM 
treatment. It is a humanized monoclonal antibody against 
vascular endothelial growth factor that act as angiogenesis 
inhibitor.6 Side effects of chemotherapy are often severe, 
including nerve damage, nausea, hair loss, and infertility 
(Figure 1). Chemotherapy in combination with other thera-
pies, especially RT, provides the most effective treatment 
strategy for GBM at the moment.5 For instance, a Phase III 
study conducted by the European Organization for Research 
and Treatment of Cancer and the National Cancer Institute 
of Canada reported that combined therapy of RT and temo-
zolomide increased median survival time significantly when 
compared with RT alone.7 The 5-year overall survival rate 
was 9.8% for the combination therapy group versus 1.9% for 
the RT alone group, with a median follow-up of 61 months. 
This and other studies are paving the way toward new treat-
ment combinations.
Hyperthermia
Hyperthermia is a fairly new concept that finds its applica-
tion in the treatment of different types of cancers and is 
based on generation of heat at the tumor site. This results in 
changes in the physiology of diseased cells, finally leading 
to apoptosis.8
Hyperthermia treatment mechanisms involve intracellular 
heat stress in the temperature range of 41°C–46°C, result-
ing in activation and/or initiation of many intracellular and 
extracellular degradation mechanisms. The intracellular and 
extracellular effects of hyperthermia include protein misfold-
ing and aggregation, alteration in signal transduction, induc-
tion of apoptosis, changes in potential of hydrogen (pH), and 
reduced perfusion and oxygenation of the tumor.8
The effectiveness of hyperthermia treatment greatly 
depends on the temperature profile at the targeted tumor site, 
duration of exposure, and characteristics of cancer cells.9,10 
Traditionally, hyperthermia treatment was performed using 
external devices to transfer thermal energy to cancerous tis-
sues, either by irradiation with light or electromagnetic waves. 
Conventional techniques for induction of hyperthermia are 
ultrasound, microwaves, infrared irradiation, and tubes with hot 
water. However, each of these methods suffers from limitations 
(Table 1),10 including low penetration of heat in the tumor; 
excessive heating of healthy tissue; thermal under-dosage in 
the target region; and dissipation of heat by the blood, which is 
especially a problem in well-vascularized tumors.10,11
To overcome these limitations, magnetic materials were 
first proposed for hyperthermia treatment of cancer in 1957.12 
Many approaches have evolved since then to develop a new 
therapeutic system called magnetic hyperthermia therapy 
(MHT). MHT is based on generation of heat by magnetic 
nanoparticles (MNPs) when exposed to alternating magnetic 
fields. When MNPs are injected in the tumor and an alternat-
ing magnetic field is applied, the tumor temperature rises and 
results in thermal ablation of tumor cells.13 MHT encompasses 
many salient features including externally-stimulated intra-
cellular heating, delivery through multiple routes, potential to 
cross the blood–brain barrier, and antitumoral immunity.13,14
Nanoparticle-based hyperthermia
MNPs
In the last decade, several types of iron oxides have been 
explored to synthesize MNPs, including magnetite (Fe3O4), 
hematite (α-Fe2O3), and maghemite (γ-Fe2O3 and β-Fe2O3).15 
MNPs are the most frequently investigated nanoparticles for 
Radiation therapy Chemotherapy New therapies
Drugs Virotherapy/gene therapy
Antiangiogenic therapy
Ability to infect and destroy cancer cells
Treats wide range of solid tumors
Low toxicity
Able to treat recurrent GBM
Toxicity–hypertension, proteinuria et al
Suitable for patients with HGG
Increased patient survival
Low toxicity
Potent inhibitor of tumor growth
Delivery of microRNAs a challenge
Early stages of development
Immunotherapy
MicroRNA therapy
Temozolomide, carmustine,
cisplatin, bevacizumab, irinotecan
Steady control over spread of cancer
Toxicity–nerve damage, nausea,
hair loss and infertility
Suitable for early stage cancer
Limited effectiveness against
metastasized cancer
Toxicity–skin disorders and
infertility
Figure 1 Current treatment options for glioblastoma multiforme patients.
Abbreviations: GBM, glioblastoma multiforme; HGG, high-grade glioma; RNA, ribonucleic acid.International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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biomedical applications because of their biocompatibility.15 
Among MNPs, superparamagnetic iron oxide nanoparticles 
(SPIONs) are the nanoparticles of choice due to their unique 
optical and magnetic properties, such as high paramagnet-
ism, coercivity, magnetic susceptibility, and low Curie 
temperature.16
Coercivity and Curie temperature are two important prop-
erties for nanoparticles. Coercivity of ferromagnetic material 
is a measure of intensity of the applied magnetic field that is 
required to reduce the magnetization of a material to zero.17 
Thus, coercivity measures the resistance of ferromagnetic 
material to demagnetize. Curie temperature is the temperature 
where the permanent magnetism of material changes to induced 
magnetism. When the Curie temperature is known, overheating 
of tumor tissue can be avoided, and thus side effects on healthy 
tissue can be limited.18   Preliminary   studies have suggested that 
MHT has potential to be applied for treatment of GBM. In fact, 
SPIONs have shown uniform intratumoral distribution and 
controlled heating of GBM without major side effects.19
For the application of MNPs in MHT, their physical 
and chemical properties need to be optimized, which is a 
  technological challenge. The next section discusses strategies 
for synthesis of different types of MNPs.
Methods for the synthesis of MNPs
Methods that are most commonly used for MNP synthesis 
are chemical coprecipitation, thermal decomposition, and 
microemulsion (Figure 2). Other less commonly used 
methods include hydrothermal synthesis, sonochemical 
synthesis, and electrochemical synthesis.20 Control of 
size, stability, biocompatibility, and monodispersion of 
nanoparticles are some of the most important factors to 
consider before selecting a synthesis route.20 The three 
most commonly used methods to synthesize MNPs are 
discussed here.
Chemical coprecipitation
In this method, hydrolysis of a mixture of Fe2+ and Fe3+ ions 
in 2:1 molar ratio is carried out under inert atmosphere. 
Ferrous and ferric ions are mixed in a 2:1 molar ratio at pH 
8–14. Magnetite precipitates after being formed according 
to the following reaction:
  Fe2+ + 2Fe3+ + 8OH– → Fe3O4 + 4H2O   (1)
Structural characteristics, such as size, dispersion, and 
morphology, of MNPs mainly depend on the type of salts 
Table 1 Types of hyperthermia therapy in cancer treatment
Hyperthermia type Delivery mode Advantages Disadvantages
Thermal conduction Heated water None Heat penetration up to 3–5 mm
Radiation hyperthermia Lower frequency waves Moderate penetration Hyperthermia of healthy tissues
Magnetic induction hyperthermia Magnetic field Deep penetration Toroidal heating pattern and 
low magnetic energy absorption
Ultrasound power deposition Pressure waves Optimization of penetration  
by modulating frequency
Limited application in anatomic 
body locations
Chemical coprecipitation Thermal decomposition Microemulsion
Advantages
Simplicity
Low cost
Significant size control
High crystallinity
Uniform size
Size controllability
Colloidal stability
None
None Multistep process
Poor size distribution
Disadvantages
Advantages
Disadvantage
Advantages
Disadvantage
Synthesis strategies–Magnetic NPs
Figure 2 Methods for the synthesis of magnetic nanoparticles.
Abbreviation: NPs, nanoparticles.International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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used, the ratio of ferric and ferrous ions, and the reaction 
  temperature.21 Coprecipitation synthesis involves two major 
steps: first, formation of nuclei and second, growth of nuclei. 
The advantage of coprecipitation synthesis is the possibility 
to synthesize industrial quantities of nanoparticles. Large 
size distribution is the most common problem associated 
with coprecipitation. To overcome this problem reaction 
conditions are varied, such as pH, temperature, nature and 
origin of salts, and the Fe3+/Fe2+ ratio.21,22
Thermal decomposition
Thermal decomposition is carried out in an organic   solution 
and results in formation of monodispersed iron oxide 
  nanoparticles, with significant size control and   crystallinity. 
Thermal decomposition involves decomposition of iron com-
plexes in the presence of surfactants and organic solvents at 
high temperatures.23
Sun and Zhang24 prepared SPIONs using thermal 
  decomposition. Reactions of iron (III) acetylacetonate were 
performed at a high temperature (265°C) in the presence of 
phenyl ether, alcohol, oleic acid, and oleylamine to form 
SPIONS with a diameter of 4 nm. Hyeon et al25 synthesized 
SPIONs with a diameter of 7–25 nm by thermal decomposi-
tion. In their study, nanoparticles were synthesized as iron 
oleate complexes from iron pentacarbonyl by decomposi-
tion in the presence of octyl ether and oleic acid at 100°C. 
Park et al26 used iron salt (iron chloride [FeCl3 ⋅ 6H2O]) 
instead of toxic ferrous metallic compounds as precursor to 
form an iron-oleic complex. Iron-oleic complexes yielded 
monodispersions of iron oxide crystals when mixed with 
sodium oleate in the presence of 1-octadecene and aged 
for 30 minutes.
Microemulsion
Iron oxide nanoparticles generated in the presence of micro-
emulsions yield nanoparticles of uniform size and colloidal 
stability. Inouye et al were the first to synthesize MNPs in 
microemulsion by oxidation of Fe2+ salts, and the size of 
MNPs was controlled by varying temperature and surfactant 
concentration.27 Micelles have been immensely useful in 
synthesizing monodispersed, size-controlled nanoparticles. 
Lee et al used reverse micelles (micelles with head groups 
in the center and tails at the periphery) for the synthesis 
of SPIONs.28 This method to generate monodispersed 
SPIONs is efficient, inexpensive, and large-scale, and it 
involves   synthesis of MNPs at high temperatures using iron 
salts, surfactant, and solvents in varying concentrations or 
proportions.28
Methods for the surface modification of MNPs
MNPs are susceptible to corrosion. The most common form 
of corrosion that occurs in MNPs is oxidation, which leads 
to loss of magnetism and dispersibility of nanoparticles, thus 
affecting their ability to induce hyperthermia. Therefore it 
is necessary to protect MNPs from oxidation. Methods that 
have been explored to protect MNPs against oxidation include 
surface modification by surface passivation, surfactant and 
polymer coating, and metal, silica, and carbon coating. 
A detailed review on this topic has already been published. 
A brief overview of methods for surface modification of 
MNPs is presented below.
Surface passivation by mild oxidation
Surface passivation is the protection of any material from 
external environmental factors, and surface passivation 
by mild oxidation has been used for protecting MNPs.29,30 
Peng et al used plasma gas condensation to oxidize cobalt 
  nanoparticles in gas phase.29 Bönnemann et al used con-
trolled air atmosphere to oxidize cobalt nanoparticles, and 
this resulted in the formation of an outer layer of cobalt 
oxide on the nanoparticle and protected it from further 
oxidation.30
Surfactant and polymer coating
MNPs synthesized through coprecipitation carry negatively 
charged surfaces, causing them to agglomerate. Surfactants 
and polymers have been peptized, chemically anchored, or 
physically adsorbed on MNPs to form stable colloids.31–33 
These stable colloids create repulsive forces to balance the 
magnetic and the van der Waals attractive forces acting 
on the nanoparticles, thus preventing nanoparticles from 
agglomeration. Polymers that have been used for the formation 
of stable colloids are poly(pyrrole), poly(aniline), poly(alkyl 
cyanoacrylates), poly(methylidene malonate), poly(lactic 
acid), poly (glycolic acid), and poly(e-caprolactone).34–37
Metal, silica, and carbon coating
Precious metals deposited onto MNPs protect the magnetic 
nanoparticle core from oxidation. Of all precious metals, 
gold is the metal of choice for coating MNPs due to its 
low reactivity. However, direct coating of gold onto MNPs 
is   difficult because of the dissimilar nature of the two 
surfaces.38,39 Despite this complication, many   researchers have 
been able to coat MNPs with gold by using new techniques. 
Ban et al synthesized gold-coated iron nanoparticles using 
a partial replacement reaction in a polar aprotic solvent,40 
Liu et al synthesized gold-coated iron nanoparticles using a International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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reverse microemulsion method,41 and Zhang et al synthesized 
iron (core) gold (shell) nanoparticles using a combination of 
wet chemistry and laser irradiation.42
Gold nanorods
Gold nanorods (GNRs) exhibit optical properties that depend 
on size and aspect ratio. Surface plasmon resonance is the 
most important property of GNRs. It is a result of   interaction 
between electrons in a conduction band of gold atoms 
and electric field components of incident electromagnetic 
  radiation.43 As a result of surface plasmon resonance, GNRs 
emit heat upon irradiation with an infrared laser. This prop-
erty was used in numerous studies to develop photodynamic 
therapy for GBM treatment.44 The most efficient strategies 
for the synthesis of GNRs of different aspect ratios and sizes 
are discussed here.
Methods for the synthesis of GNRs
GNRs can be synthesized by either wet or dry chemistry. Wet 
chemistry is the preferred mode of synthesis because of its 
simplicity and low costs.45 In the following subsections, three 
major synthesis methods are reviewed: the template method, 
the electrochemical method, and the seed-mediated growth 
method (Figure 3).
Template method
The template method for synthesis of GNRs involves 
electrochemical deposition of gold onto the pores of an 
alumina template membrane or nanoporous polycarbonate. 
The method was originally used to prepare microscopic 
  electrodes by depositing gold onto a polycarbonate 
  membrane using electroplating. Genzel et al were the first to 
successfully employ the template method for the synthesis 
of GNRs.46
The method involves four steps. In the first step, copper 
is sputtered onto an alumina template. In the second step, 
gold is electrodeposited onto the nanosized pores of alumina. 
In the third step, the alumina membrane and copper film 
are dissolved in the presence of an appropriate stabilizer. 
In the final step, GNRs are dispersed in water or an organic 
solvent using ultrasonic waves or agitation. GNRs of vari-
ous diameters and lengths have been successfully generated 
using the template method. The diameter of nanorods is 
controlled by the pore diameter of the template, and the 
length is controlled by the quantity of gold deposited within 
the membrane nanopores.45
electrochemical method
The electrochemical method is the most commonly used 
method for the synthesis of transition metal clusters in an 
organic solvent. Nikoobakht et al developed the application 
of an electrochemical method for the synthesis of GNRs 
and synthesized GNRs in high yields.47 The actual synthe-
sis was conducted in an electrochemical cell containing 
two   electrodes. In the cell, a gold metal plate was used as 
anode, and a platinum plate was used as cathode. The final 
electrolysis was carried out in the presence of a   hydrophilic 
cationic surfactant and a controlled current mode for 
30–60 minutes to successfully synthesize GNRs.47
A recent study used a silver plate to control the aspect 
ratio of GNRs.48 Silver metal reacted with gold ions to 
generate silver ions at the anode. The amount of silver 
Template method
Synthesis strategies–Gold nanorods
Advantages
Tunable aspect ratio
Tunable rod size
Tunable aspect ratio
Tunable shape and size
High yield
Additional step for shape seperation
High yield
Colloidal stability
Multistep synthesis
Cost
Cost
Disadvantages
Advantages
Disadvantages
Advantages
Disadvantages
Electrochemical method Seed–mediated growth
 method
Figure 3 Methods for the synthesis of gold nanorods.International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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ions and their release rates were found to affect the length 
of GNRs.48
Seed-mediated growth method
The seed-mediated growth method has been used for 
decades to synthesize monodispersed metal nanoparticles. 
Brown et al were the first to use the seed-mediated growth 
method for the synthesis of GNRs by reducing auric gold 
(Au3+) with hydroxylamine.49 One of the major biocom-
patibility issues of the seed-mediated growth method is 
the formation of nanoparticles of other shapes along with 
nanorods.
Jana et al synthesized GNRs using 3.5 nm seed 
nanoparticles.50 The yield of this method was 4%, but it was 
later improved by changing the pH of the growth solution 
from 2.8 to 5.6. The change in pH resulted in formation of 
GNRs with an aspect ratio between 18 and 20 and a yield of 
90%.51 Hu et al used various temperatures and capping agents 
for GNR synthesis.52 It appeared that a reduced temperature 
and the use of hexadecyltrimethylammonium bromide as 
capping agent led to nanorods with an aspect ratio between 
1 and 6 and a yield in the order of 50%. The study also 
suggested that stability of seeds, growth temperature, and 
concentration of surfactant influence monodispersity, yield, 
and aspect ratio.
The seed-mediated growth method does not only generate 
nanorods but also nanoparticles of various shapes. For this 
reason, separation of nanorods from other nanoparticles is 
critical. Methods such as size-selective precipitation, nanopo-
rous filtration, and methods for extraction have successfully 
separated nanospheres of different sizes but are not very 
selective for nanorods due to their relatively large size.53,56 
Wei et al demonstrated that size-exclusion chromatography 
can separate nanorods from spheres, but this method is only 
partly successful.54 Jana used   phase-separation involving 
surfactant-assisted ordering.55 The method successfully 
separated single-sized nanorods from a mixture of differently-
sized rods, spheres, and plates. More recently, Sharma et al 
demonstrated centrifugation as an efficient technique to sepa-
rate nanorods from a mixture of nanorods and nanospheres.56   
The technique is based on the fact that shape-dependent 
drag causes particles to have shape-dependent sedimenta-
tion behavior.
Methods for the surface modification of GNRs
GNRs synthesized using the above mentioned methods 
have dispersion and biocompatible flaws and there-
fore need   further surface modification before use as 
hyperthermia agents.57 There are two main strategies for 
surface modification of GNRs: matrix entrapment and 
ligand exchange.
Matrix entrapment
Entrapment of GNRs in a matrix improves their disper-
sion and optical and chemical characteristics. Mitamura 
et al entrapped and dispersed GNRs in an alginate matrix 
using energy dispersive X-ray spectroscopy. Alginate 
entrapped GNRs were highly dispersed and maintained 
their optical   character.58 Apart from alginate, poly(N-
  isopropylacrylamide) gel has also been used to disperse 
GNRs in a gel matrix. Gorelikov et al59 and Kumar et al60 
dispersed GNRs in a poly(N-  isopropylacrylamide) microgel 
using hybridization. The resulting hybrid gel was unique in 
that it was able to   reversibly shrink with or without infrared 
radiation.
Ligand exchange
Surfactants used in the seed-mediated growth method for 
synthesis of GNRs are toxic. Ligand exchange has been the 
method of choice for removal of residual surfactants from 
GNRs. Gentili et al used a double phase transfer process for 
surface functionalization of GNRs.61 The process consisted 
of a simple one-step ligand exchange in a hydroalcoholic 
mixture with thiols and a phase transfer to entrap gold 
nanoparticles into polyethylene glycol-based polymeric 
nanoparticles. Thus, the obtained GNRs were lipophilic-free 
with a robust coating. Khanal et al synthesized GNRs stabi-
lized by cetyltrimethylammonium bromide and subsequently 
exchanged the cetyltrimethylammonium bromide for a func-
tional thiol using 4-mercaptophenol.62 The method resulted 
in formation of anisometric GNRs that self-assembled into 
ring-like superstructures.
Carbon nanotubes
Carbon nanotubes (CNTs) were first observed in 1952 by 
Radushkevich and Lukyanovich, but only in 1991 was a 
methodology for the synthesis of CNTs described by Iijima 
using C60 carbon molecules.63,64 CNTs are most commonly 
synthesized from allotropes of carbon in two different forms, 
such as single-walled carbon nanotubes (SWNTs) and multi-
walled nanotubes (MWNTs). SWNTs consist of a single 
tube of graphene, and MWNTs consist of several concentric 
tubes of graphene (Figure 4). Both forms have unique physi-
cal and chemical properties that enable their application in 
anticancer hyperthermia therapy. CNTs generate heat upon 
infrared irradiation. Another salient feature of CNTs is the International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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possibility to engineer their surface for conjugation with a 
wide variety of molecules.64
Methods for synthesis of CNTs
There are three major techniques for the synthesis of CNTs: 
arc discharge, laser ablation, and chemical vapor deposition 
(CVD). Arc discharge and laser ablation were the initial 
techniques used to synthesize CNTs. Both techniques require 
high temperatures (generally .1,700°C) and are now more 
or less obsolete, replaced by CVD which is carried out at 
comparatively low temperatures (,800°C) and enables the 
synthesis of CNTs with controlled orientation, alignment, 
length, diameter, and density.65
Arc discharge
Arch discharge is a gas phase reaction process requiring 
high temperatures for synthesis of CNTs. The advantage of 
arc discharge is that CNTs with minimal imperfections and 
structural defects are generated. The process conditions are 
different for the synthesis of MWNTs and SWNTs.
Synthesis of MwNTs
Graphite electrodes are used for synthesis of MWNTs. The 
electrodes have a diameter of 8–12 nm and are water cooled. 
The reaction atmosphere consists of helium, hydrogen, or 
methane. The purity and yield of CNTs are found to vary 
with the gas atmosphere and pressure inside the reaction 
vessel. Wang et al used evaporation in methane under high 
pressure and high arc current to obtain thick nanotubes.66 
Lowering the methane pressure and the current at the anode 
resulted in formation of thin and long MWNTs. Zhao et al 
used hydrogen gas instead of methane as reaction atmosphere 
and also obtained thin and long MWNTs.67
Another technique for arc discharge deposition is the use 
of pulsed current rather than direct current. Parkansky et al 
used a single-pulse arc to produce MWNTs with a diameter 
of 10 nm and a length of 3 µm.68 In addition to standard arc 
deposition, alternative methods have been used for synthesis 
of CNTs. Sornsuwit et al69 and Montoro et al70 used arc dis-
charge in an aqueous vanadic acid solution to grow high qual-
ity SWNTs and MWNTs. Jung et al used arc discharge in the 
presence of liquid nitrogen to successfully grow MWNTs.71
Synthesis of SwNTs
Unlike MWNTs, SWNTs cannot be synthesized in the 
absence of a transition metal catalyst. The most commonly 
used method for the synthesis of SWNTs is based on an arc 
discharge system fitted with a composite anode. The compos-
ite anode consists of graphite and a combination of transition 
metals as catalyst. The catalyst plays an important role in 
increasing the yield of the process while high efficiency is 
ensured by a constant gap between electrodes.
Iijima et al were the first to synthesize SWNTs in 1993.72 
Later that year, Bethune et al utilized coevaporation of 
carbon and cobalt to generate SWNTs with a single atomic 
layer.73 Chen et al modified the electric arc technique for 
the synthesis of SWNTs by using a ferrium-hydrogen arc 
discharge.74 This new technique used hydrogen arc discharge 
with a carbon anode containing a 1% iron (Fe) catalyst in a 
mixed   hydrogen-argon gas environment to produce highly 
Figure 4 Structural arrangement of carbon in (A) single-walled nanotube and (B) multiwalled nanotube.International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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  crystalline SWNTs. The technique successfully generated 
SWNTs with a purity .90%. Fan et al further modified this 
technique to develop an economic process for the synthesis of 
SWNTs.75 The technique used argon as reaction atmosphere 
and direct current arc discharge with charcoal as carbon 
source and iron sulfide and cobalt oxide as catalyst. SWNTs 
thus formed were highly pure with a diameter of 1.2 nm.
CvD
Arc discharge enables the generation of large quantities of 
CNTs with minimal imperfections but with low purity. CVD 
on the other hand produces CNTs with predefined properties 
and high purity.
CVD involves catalytic decomposition of hydrocarbon 
or carbon monoxide feedstock, with the aid of supported 
transition metal catalysts to produce CNTs. The synthesis 
is achieved by combining a carbon source with an energy 
source. Most commonly used energy and carbon sources 
are a plasma- and resistively-heated coil, methane, carbon 
monoxide, and acetylene. There are three main steps in the 
synthesis process.76 The first step is the cracking step, where 
the energy source is used to crack the gas phase molecule into 
atomic carbon. The second step is the diffusion step, during 
which cracked atomic carbon diffuses toward the substrate. 
The third step is the heating and coating step. During this step, 
diffused carbon is heated and coated with the metal catalyst 
while it binds to the catalyst. Excellent diameter control and 
growth rate can be achieved with CVD. The actual process 
for synthesis of CNTs consists of a catalyst preparation step 
that is followed by the actual synthesis of the nanotube. The 
catalyst preparation is performed by using either sputtering 
or chemical etching. The temperatures for the synthesis of 
nanotubes by CVD are usually within the 650°C–900°C 
range. Typical yields for CVD are approximately 30%.77
CVD has been used to create several structural forms of 
carbon, including SWNTs and MWNTs from well-crystallized 
graphite layers. CVD allows selective CNT growth in a variety 
of forms, such as powder and an aligned forest of CNTs.78,79
In the last decade, different CVD-based techniques 
have been developed for CNT synthesis, including plasma-
enhanced CVD, thermal-chemical CVD, alcohol-catalytic 
CVD, vapor phase growth, aero gel-supported CVD, and 
laser-assisted CVD.80
Hyperthermia with MNPs
Hyperthermic therapy
Hyperthermia using MNPs is often referred to as MHT. MHT 
involves injection of iron oxide nanoparticles inside the tumor 
and subsequent placement of the patient in an alternating 
magnetic field, which results in an increased intratumoral 
temperature, thermal ablation of tumor cells, and subsequent 
tumor shrinkage.
MHT is advantageous in two ways. First, MNPs accu-
mulate in the tumor. Therefore, healthy tissue damage is 
limited. Second, MHT is noninvasive and capable of inducing 
hyperthermia in tumors at any location in the body. However, 
the efficiency of therapy is highly variable and often found 
to be dependent on particle properties, including size, mag-
netization, and Curie temperature. Curie temperature is an 
important parameter, indicating the maximum temperature of 
a magnetic particle. A good estimate of the Curie temperature 
allows an efficient temperature control and is thus critical 
to avoid overheating of tissue by MNPs. Besides particle 
properties, other parameters that play an important role in 
determining efficiency of MHT are intensity and frequency 
of the alternating magnetic field and the dissipation of heat 
from the tumor.
The effectiveness of MHT in glioma was first reported by 
Shinkai et al.81 In their first study, the group used an ex vivo 
rat model implanted with glioma cell pallets and magnetic 
cationic liposomes. Three doses of alternating magnetic field 
for 60 minutes each, at intervals of 12 hours were applied 
to the rats. The treatment was reported to completely inhibit 
tumor development for up to 90 days.81 In the second study, 
an in vivo rat model was used to examine the effect of hyper-
thermia in glioma tumors.82 Magnetite cationic liposomes 
were administered to rats, and histological analysis revealed 
that the rats that were exposed to the magnetic field showed a 
homogeneous distribution of magnetite cationic liposomes, 
which also coincided with the necrotic regions. In the third 
study, an in vivo model of rat with glioma tumors was used to 
study antitumor immunity of rats by hyperthermia   therapy.83 
During the primary treatment, three doses of 30 minutes 
each were applied at 24-hour intervals. Tumor tissue was 
completely eliminated in two-thirds of the rats. These rats 
were rechallenged with glioma cells 3 months later. Transient 
growth was observed in the initial 2 weeks, but the tumors 
disappeared in 4 weeks. The explanation for this  phenom-
enon was promotion of anti-tumor response by activation of 
heat shock proteins (see below).
In the last two decades, other studies have also demon-
strated the effectiveness of MHT, on its own as well as in 
combination with other therapies. Ito et al observed that 
hyperthermia promotes an anti-tumor immune response 
by activation of heat shock proteins.84 In a later study, 
it was   suggested that hyperthermia in combination with 
gene therapy is an effective strategy for the treatment of 
GBM.85 Le et al demonstrated increased effectiveness of International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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magnetite cationic liposomes in the destruction of GBM 
tissue by   conjugating magnetic cationic liposomes to a 
specific antibody against GBM.86 Table 2 shows a compre-
hensive list of in vivo studies that evaluated SPIONs for 
GBM treatment.
Latest clinical trials in Europe suggest that the application 
of magnetic hyperthermia may become clinically effective 
soon. MagForce Nanotechnologies (Berlin, Germany) has 
developed a MHT system called “NanoTherm®.” The system 
is based on aminosilane-coated SPIONs and the applica-
tion of an alternating magnetic field. This MHT system has 
received approval in Europe to use iron oxide MNPs for 
GBM treatment.87
Hyperthermia as enhancer  
of drug delivery
The term “hyperthermia” has thus far been confined to the 
use of heat for therapy. However, hyperthermia has also been 
utilized as a novel mechanism to improve drug delivery to 
tumors.88 The use of magnetic field to control drug release 
from polymeric matrices containing iron oxide was first 
reported nearly 30 years ago.88,89 The MNP design for drug 
delivery is unique and generally consists of an iron oxide core 
and a polymer shell. The polymer shell is heat sensitive, and 
upon heat transferred from the iron oxide core, it contracts 
to release the encapsulated drug. MNP systems based on 
this concept are able to deliver drugs in a controlled manner. 
Control is possible because of the sensitivity of the MNP 
shell to a magnetic field, which is a function of frequency 
and strength of alternating magnetic field.90
Hyperthermia-mediated release of various drugs 
was first demonstrated using temperature-sensitive 
poly(N-isopropylacrylamide) hydrogels incorporating 
SPIONs.91 Hoare et al demonstrated on-demand release 
of sodium fluorescein using nanocomposite membranes 
of thermosensitive poly(N-isopropylacrylamide)-based 
nanogels and magnetite nanoparticles92 (Figure 5). This 
study opened avenues for the development of therapeu-
tic systems such as magnetic micro- and nanopumps, 
magnetic field-controlled drug delivery devices, and 
magnetic switches.
A more recent design of a magnetic drug delivery plat-
form is magnetic composite nanoparticles consisting of 
multiple metals. Behrens et al demonstrated the potential 
of ferromagnetic cobalt nanoparticles in modulating the 
permeability of polyelectrolyte microcapsules.93 In this 
study,   ferromagnetic gold-coated cobalt nanoparticles were 
embedded inside polymeric walls using the layer-by-layer 
self-assembly technique. The polymer capsules consisted 
of eleven layers, with one layer of ferromagnetic gold-
coated cobalt nanoparticles and ten layers of polyelectrolyte 
  bilayers. The polymer capsule design was found to be ideal 
for the magnetic control of the permeability of the composite 
nanoparticle.
Another interesting type of MNPs for drug delivery is 
iron-core and silica-shell nanoparticles. This nanoparticle 
design is unique because it protects biomolecules that 
are encapsulated in the shell from the environment. The 
core-shell nanoparticles resemble extracellular vesicles. 
  Extracellular vesicles are small granules that are produced 
by cells in our body to deliver biological materials to recipi-
ent cells.94
More recently, implantable microchips have been devel-
oped on the basis of MNPs, such as a novel drug-delivery 
chip for magnetically-controlled release of anti-epileptic 
drugs95,96 (Figure 6). The chip was made of an electrically-
conductive flexible polyethylene terephthalate substrate that 
contained drug-loaded magnetic SPION-core-silica-shell 
nanoparticles.
Hyperthermia with GNRs
Hyperthermic therapy
Gold nanoparticles possess unique optical properties of 
which surface plasmon resonance is the most important. 
Table 2 In vivo animal model studies to evaluate MHT using SPION for thermal ablation of GBM
Study Tumor  
cell line
Animal Sex Age  
(weeks)
Injection site Minimum 
inoculation (cells)
Jordan et al19 RG-2 Fisher rat F-344 Male – Thalamus region 1×106
Shinkai et al81 T9 Fisher rat F-344 Female 6–7 Subcutaneous (left femoral region) 1×106
Yanase et al82 T9 Fisher rat F-344 Female 7–8 Subcutaneous (left femoral region) 1×106
Yanase et al83 T9 Fisher rat F-344 Female 6–7 Subcutaneous (left femoral region) 1×106
Ito et al84 U-251-SP Athymic nude mice Female 4 Subcutaneous (left and right femoral 
regions)
1×106
Ito et al85 T9 Fisher rat F-344 Female 6 Subcutaneous space 1×106
Le et al86 U-251-SP KSN – nu/nu nude mice Female 4 Subcutaneous (femoral region) 1×106
Abbreviations: GBM, glioblastoma multiforme; MHT, magnetic hyperthermia therapy; SPION, superparamagnetic iron oxide nanoparticles.International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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Surface plasmon resonance is the collective oscillation of 
electrons in a solid or liquid state stimulated by incident 
light. In the case of gold nanoparticles, absorption of infrared 
light induces   surface plasmon resonance that is converted 
into heat. GNRs have the greatest potential for biomedical 
applications because of their high light absorption efficiency 
per unit volume. GNRs exhibit two distinct surface plasmon 
oscillations: a strong band in the near infrared region, 
corresponding to electron oscillation along the long axis 
(longitudinal band) and a weak band in the visible region 
(transverse band). Only the longitudinal band is sensitive to 
size changes and can be shifted from the visible to the near 
infrared region by adjusting the aspect ratio (length/width) 
during synthesis.97
GNRs have attracted great interest for hyperthermic 
therapy due to superior biocompatibility. The effective-
ness of GNRs in hyperthermic anti-tumor therapy has been 
  demonstrated.97 GNRs have been conjugated with molecules 
that carry sequences that can bind to cancer biomarkers. 
These GNRs specifically target and destroy tumors. Oral 
cancers are known to overexpress folate receptors, and there-
fore many studies utilized GNR conjugated with folic acid to 
target oral cancer cells. The study successfully ablated oral 
cancer cells in a targeted manner.98 Choi et al used   PEGylated 
GNRs conjugated with an Arg-Gly-Asp sequence to specifi-
cally bind to αvβ3 integrins expressed on GBM cells.99 The 
study demonstrated that (Arg-Gly-Asp)-GNRs are able to 
circulate for prolonged periods of time and bind to GBM 
cell surface, thus targeting GNRs to the GBM tumor. Fer-
nandez et al developed an optical hyperthermia method for 
treatment of GBM by irradiation of GNRs by laser light and 
was successful in ablating GBM cells in vitro.100 Oli et al 
used folate-conjugated GNRs to specifically target GBM 
cells.101 The study showed that folate-conjugated GNRs can 
successfully target and kill GBM cells upon excitation with 
a near infrared laser.
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Hyperthermia as enhancer of drug 
delivery
GNRs have also been studied as enhancers of drug deliv-
ery. GNRs offer tunable and localized surface plasmon 
resonance, which makes them highly localized heat sources 
when irradiated with a laser. The heat generated by GNRs is 
used for hyperthermic cancer therapy and/or to trigger the 
release of a drug.
Although drug delivery using GNRs is a new field, there 
are two major studies that investigated the use of GNRs to 
deliver doxorubicin to GBM. Agarwal et al were the first to 
study remotely triggered release of doxorubicin in GBM 
tumors using thermosensitive liposomes and GNRs.102 
  PEGylated GNRs triggered release of doxorubicin from 
thermosensitive liposomes in a mouse tumor model of 
human GBM when irradiated with near infrared light. The 
stimulation resulted in significantly increased efficacy when 
compared to nontriggered or nonthermosensitive PEGylated 
liposomes. More recently, Xiao et al studied GNRs conju-
gated with doxorubicin and cyclo(Arg-Gly-Asp-D-Phe-Cys) 
peptide for drug delivery in GBM.103 Doxorubicin was 
covalently conjugated to PEGylated GNRs via a hydrazone 
bond. Flow cytometric analysis revealed that GNRs conju-
gated with doxorubicin and cyclo(Arg-Gly-Asp-D-Phe-Cys) 
peptide exhibited a higher cellular uptake and cytotoxicity 
than nontargeted GNRs conjugated with doxorubicin in 
human GBM cells.
Zhang et al evaluated the potential of mesoporous silica-
coated GNRs for cancer theranostics in a proof of concept 
study in human alveolar adenocarcinoma cells.104 The core 
of GNRs functioned both as an agent that allowed noninva-
sive imaging as well as a hyperthermic agent while the outer 
mesoporous silica shell encapsulated a high drug load, thus 
posing itself as an effective drug carrier (Figure 7).
Hyperthermia with CNTs
Hyperthermia using CNTs is a new field compared to MNP- 
and GNR-mediated hyperthermia. CNTs exhibit unique 
physical and chemical properties that hold promise for drug 
delivery and cancer therapy.105 The mechanisms of selective 
tumor targeting with CNTs are currently being explored due 
to their impressive ability to convert near infrared light into 
heat. This intrinsic property of CNTs opens new avenues 
for the development of novel nanostructures for cancer 
phototherapy.105
Markovic et al used CNTs and graphene nanoparticles 
for hyperthermic ablation of human glioma cells in vitro.106 
The study showed that graphene nanoparticles triggered cell 
death by inducing oxidative stress, and CNTs triggered cell 
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Figure 7 Mechanism of action of mesoporous silica-coated gold nanorods (A), gold 
nanorods without coating (B), and mesoporous silica-coated GNRs (C).
Notes: The core of GNRs functioned both as an agent that allowed noninvasive 
imaging as well as a hyperthermic agent while the outer mesoporous silica shell 
encapsulated  a  high  drug  load,  thus  posing  itself  as  an  effective  drug  carrier. 
Reproduced  from  Zhang  Z,  Wang  L,  Wang  J,  et  al.  Mesoporous  silica-coated 
gold nanorods as a light-mediated multifunctional theranostic platform for cancer 
treatment. Adv Mater. 2012;24(11):1418–1423.104 Copyright © 2012 wILeY-vCH 
verlag GmbH & Co. KGaA, weinheim.
Abbreviations: Au@SiO2, silica-coated gold nanorods; DOX, doxorubicin; GNRs, 
gold nanorods.
death via mitochondrial membrane depolarization. Wang 
et al incubated GBM cells with anti-CD133 monoclonal 
antibody-conjugated SWNTs,107 and irradiation with near 
infrared laser light resulted in targeted ablation of GBM 
cells while the viability of control cells remained unaf-
fected. In a second study, Wang et al generated anti-GD2-
conjugated CNTs to target GD2 receptors present on the 
surface of neuroblastoma cells.108 Neuroblastoma cells were 
pretreated with anti-GD2-conjugated CNTs and were then 
irradiated with a near infrared laser. Postexposure analysis 
revealed necrosis among GD2-positive cells, whereas GD2-
negative   (control) cells remained unaffected. These studies 
suggest that SWNTs and MWNTs possess unique optical International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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Dovepress
2874
verma et al
properties that have potential to develop novel therapies for 
the treatment of GBM.
Conclusion
GBM is an aggressive tumor type with very low survival 
rates. Many factors attribute to the low survival rates; 
some are inherent while others are treatment dependent. 
  Conventional therapies lack specificity for cancer cells 
and therefore lead to side effects. Conventional therapies 
in combination with alternative or adjuvant therapies 
provide a better treatment strategy but still lack the effi-
cacy and potential that is needed for effective treatment 
of GBM.
Conventional hyperthermia with external devices has 
been used for a long time but lacks accurate temperature 
control, leading to overheating and damage of healthy tissue 
or dissipation of heat from the tissue. Hyperthermia using 
nanoparticles is a novel concept that enables controlled heat-
ing of tumor tissue. Nanoparticle-based hyperthermia can 
have direct therapeutic effects and enhance drug delivery 
in a single therapy, making it a therapy with two advantages   
for cancer treatment.
MNPs, GNRs, and CNTs are the most promising nano-
particles for hyperthermic therapy in GBM. Among MNPs, 
SPIONs are the nanoparticles of choice for treatment of 
GBM. The salient features of SPIONs are:
•  ease of synthesis;
•  superior biocompatibility; and
•  relatively low cost.
Cationic liposomes and aminosilane-coated SPIONs have 
been found to be effective in ablating GBM in the presence 
of an alternating magnetic field. MagForce Nanotechnolgies 
has commercialized MHT for the treatment of GBM after 
successful Phase I, II, and III trials.
In addition to high treatment efficacy, many studies81,82   
have also confirmed an antitumor immune response after 
hyperthermia, based on elevated expression of heat shock 
proteins, which is an added advantage.
Core-shell SPIONs, when incorporated with drugs and 
stimulated with alternating magnetic field, are capable of 
drug delivery in a controlled manner. Layer-by-layer self-
assembly is the preferred method for synthesis of core-shell 
SPIONs. Drug delivery and hyperthermia using SPIONs 
is promising yet challenging. Advantages of SPION-based 
hyperthermia are:
•  ability to cross the blood–brain barrier;
•  delivery through multiple routes;
•  minimal or no side effects;
•  noninvasive procedure; and
•  antitumoral immunity.
Some of the challenges on the other hand are moderate 
to low absorption rates, monitoring temperature distribution, 
self-regulation of heating, and precise control of intratumoral 
temperature.
Gold nanoparticles exhibit exceptional physical and 
optical properties including surface plasmon resonance. 
These properties enabled the development of novel pho-
tothermal therapies for the treatment of GBM. GNRs 
encompass better properties than gold nanospheres includ-
ing superior biocompatibility and higher light absorption 
per unit volume.
GNRs are prepared by either wet or dry chemistry. Wet 
chemistry is the preferred mode due to the simple and inex-
pensive nature of synthesis. Most investigated wet chemistry-
based methods for GNR synthesis are:
•  template;
•  electrochemical; and
•  seed-mediated growth.
When GNRs are intravenously injected in in vivo   models 
of GBM and irradiated with near infrared laser light, they 
cause significant thermal ablation of tumor cells via necrosis 
and/or apoptosis. This procedure is successful in reduc-
ing tumor volume but often leads to nonspecific heating 
of surrounding healthy tissue. Conjugation of GNRs with 
cell surface targeting antibodies or aptamers can overcome 
these nonspecific heating effects. Studies have successfully 
used αvβ3 integrins and folate receptors to target GNRs to 
GBM cells.
Core-shell GNRs are versatile nanocarriers for drug 
delivery. Studies have successfully delivered doxorubicin 
as model drug to GBM cells using targeted as well as 
  nontargeted approaches.
In  summary,  core-shell  versions  of  GNR  are 
capable of:
•  controlled drug delivery;
•  hyperthermia; and
•  combinational therapy.
Development of multifunctional systems based on core-
shell MNPs and GNRs with individual functions acting in a 
coordinated way is critical to optimize therapeutic efficacy 
and safety of therapeutic regimes, and could provide more 
opportunities for on-demand therapy and pave the road 
toward personalized medicine.
CNTs and graphene nanoparticles exhibit an impressive 
ability to convert near infrared light into heat. This intrinsic 
property of CNTs is utilized to develop hyperthermic therapy International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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for GBM treatment. The studies suggest that CNTs and 
graphene nanoparticles can effectively ablate glioma cells 
in a targeted as well as a nontargeted manner. Although 
CNTs are successful in cancer phototherapy, further studies 
are needed to elucidate all mechanisms involved in CNT-
mediated anticancer therapy.
Among MNPs, GNRs, and CNTs, SPIONs are promis-
ing in the development of MHT, GNRs are promising in 
the development of photodynamic therapy, and CNTs have 
potential in the development of photothermal therapy for the 
treatment of GBM.
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